Literature DB >> 6143935

Eicosapentaenoic acid and IgA nephropathy.

T Hamazaki, S Tateno, H Shishido.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6143935     DOI： 10.1016/s0140-6736(84)92355-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Mesangial IgA nephropathy.

Authors:  P S Kincaid-Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12

2.  [The significance of eicosanoids in glomerular diseases].

Authors:  R A Stahl
Journal:  Klin Wochenschr       Date:  1986-09-15

Review 3.  n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.

Authors:  James J Pestka
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-01       Impact factor: 4.006

4.  Influence of a diet rich in eicosapentaenoic acid on the development of rat paw oedema and on the formation of prostaglandins I2 and E2.

Authors:  W Sametz; H Juan
Journal:  Agents Actions       Date:  1985-12

5.  Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester.

Authors:  T Hamazaki; E Takazakura; K Osawa; M Urakaze; S Yano
Journal:  Lipids       Date:  1990-09       Impact factor: 1.880

6.  The effect of dietary enrichment with fish-oil on urinary excretion of N-acetyl-beta-D-glucosaminidase and renal function in proteinuric patients with primary glomerulopathies.

Authors:  J Manitius; B Sulikowska; J Fox; Z Jakubowski; E Ludwiczak; W Lysiak-Szydłowska; B Rutkowski
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

Review 7.  Omega 3 fatty acids for prevention and treatment of cardiovascular disease.

Authors:  L Hooper; R L Thompson; R A Harrison; C D Summerbell; H Moore; H V Worthington; P N Durrington; A R Ness; N E Capps; G Davey Smith; R A Riemersma; S B J Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

8.  Effect of eicosapentaenoic acid ethyl ester on proteinuria of streptozotocin-induced diabetes mellitus in rats.

Authors:  M Fujikawa; K Yamazaki; S Sawazaki; H Taki; M Kaneda; M Urakaze; T Hamazaki; S Yano; T Fujita
Journal:  Lipids       Date:  1989-09       Impact factor: 1.880

9.  [Drug treatment of chronic glomerulonephritis: pro].

Authors:  K Kühn; J Brodehl; K M Koch; U Helmchen
Journal:  Klin Wochenschr       Date:  1985-09-16

10.  Effect of dietary alpha-linolenate/linoleate balance on crescent type-anti-glomerular basement membrane nephritis in rats.

Authors:  S Watanabe; E Suzuki; R Kojima; Y Suzuki; H Okuyama
Journal:  Lipids       Date:  1990-05       Impact factor: 1.880
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.